NutriDex

The Supplement Research Compendium

Vitamin B1 (Thiamine)

The energy-metabolism spark plug — vital when deficient, inert when you're not

Strong evidence 🍊Vitamin
Evidence tier
Strong
Research weight
Citations
10 verified / 10
Classification
Vitamin
What the evidence says. Multiple high-quality RCTs / meta-analyses with consistent effects.

What is Vitamin B1 (Thiamine)?

Vitamin B1 (Thiamine) is a vitamin used for corrects and prevents deficiency syndromes — beriberi (cardiac and neuropathic) and, with prompt iv dosing, wernicke-korsakoff syndrome in alcohol-use disorder. NutriDex grades the human evidence as Strong. Thiamine (vitamin B1) is an essential water-soluble vitamin whose active form, thiamine pyrophosphate, is a coenzyme for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase — reactions central to carbohydrate metabolism and ATP production. Deficiency causes beriberi (wet/cardiac and dry/neuropathic forms) and, classically in alcohol-use disorder, Wernicke-Korsakoff syndrome; high-risk groups include heavy drinkers, those on chronic loop diuretics, bariatric-surgery and critically ill patients. In non-deficient people, supplementation trials are largely null: a 2024 meta-analysis of 7 RCTs found no improvement in LVEF in chronic heart failure, and high-dose thiamine did not relieve chronic fatigue versus placebo in a crossover RCT. The lipid-soluble derivative benfotiamine shows modest, dose-dependent symptom benefit in diabetic polyneuropathy but evidence remains limited.

Purported Benefits

Corrects and prevents deficiency syndromes — beriberi (cardiac and neuropathic) and, with prompt IV dosing, Wernicke-Korsakoff syndrome in alcohol-use disorder
Repletes high-risk groups: heavy alcohol use, chronic loop-diuretic (furosemide) therapy, bariatric surgery, hyperemesis, refeeding syndrome, and critical illness
Essential cofactor (as thiamine pyrophosphate) for pyruvate and alpha-ketoglutarate dehydrogenase and transketolase, enabling carbohydrate energy metabolism
Benfotiamine (lipid-soluble form) gives modest, dose-dependent symptom relief in diabetic polyneuropathy (BENDIP) — though not a benefit of standard thiamine in non-deficient people
No proven benefit in heart failure beyond correcting documented deficiency: a 2024 meta-analysis of 7 RCTs found no LVEF improvement
No benefit for chronic fatigue or energy in replete individuals despite popular 'energy vitamin' marketing

Evidence by outcome

The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.

OutcomeEvidenceEffectStudies
Treatment of deficiency syndromes (beriberi, Wernicke-Korsakoff)IV/oral thiamine reverses beriberi and Wernicke encephalopathy; evidence is observational/case-series but consistent, optimal dose still undefined. Strong ↑ benefit · large 3
Repletion in high-risk groups (alcohol, diuretics, bariatric, refeeding)Systematic reviews confirm deficiency is common in these groups and repletion is indicated; benefit is preventing deficiency, not enhancement. Moderate ↑ benefit · moderate 2
Diabetic polyneuropathy (benfotiamine)Single RCT (BENDIP, n=165) showed dose-dependent symptom relief, but per-protocol p=0.033 / ITT p=0.055; applies to benfotiamine, not standard thiamine. Preliminary ↑ benefit · small 1
Heart failure (LVEF in non-deficient)2024 meta-analysis of 7 RCTs (n=274) found no LVEF improvement (WMD 1.65%, p=0.24) beyond correcting documented deficiency. Moderate — no effect · negligible 1
Chronic fatigue / energy in replete individualsCrossover RCT in primary biliary cholangitis found high-dose thiamine no better than placebo for fatigue; contradicts 'energy vitamin' marketing. Preliminary — no effect · negligible 1
Septic shock mortalityMeta-analysis of RCTs with trial sequential analysis found thiamine alone did not reduce mortality (RR 0.87, 95% CI 0.65-1.16). Moderate — no effect · negligible 1

Dosing & Compounds

Typical Dose
Adult RDA: 1.2 mg/day (men), 1.1 mg/day (women); 1.4 mg/day in pregnancy and lactation. Typical supplements supply 1.5-100 mg. Therapeutic doses are far higher — e.g., 100 mg+ IV thiamine for Wernicke encephalopathy, or benfotiamine 300-600 mg/day in neuropathy trials. No Tolerable Upper Intake Level (UL) has been established; excess is readily excreted in urine.
Active Compounds
Thiamine hydrochloride (mononitrate) — standard oral supplement and food-fortification formBenfotiamine — lipid-soluble S-acyl derivative with higher bioavailability, studied in diabetic neuropathyThiamine HCl injection — IV/IM for Wernicke encephalopathy and severe deficiencyDietary sources: whole and enriched/fortified grains, pork, legumes, nuts, seeds, yeast, and fortified cereals

Safety & Cautions

Thiamine has very low toxicity and no established UL — excess oral intake is excreted renally, and adverse effects from food or supplements have not been documented. Rare anaphylactoid reactions have been reported with rapid high-dose IV administration. In suspected Wernicke encephalopathy, thiamine must be given before or with glucose, since a glucose load in a thiamine-depleted patient can precipitate or worsen encephalopathy. Chronic loop diuretics (furosemide) and heavy alcohol use increase urinary loss/impair absorption and raise deficiency risk; no major drug interactions limit supplementation itself. Educational only — always check with your doctor or pharmacist before combining Vitamin B1 (Thiamine) with any medicine.

Key Studies ★ 10 studies

meta-analysis He et al. 2024 meta-analysis ✓ Full text
Pooled 7 RCTs (n=274 chronic heart failure): thiamine produced no significant LVEF improvement (WMD 1.65%, 95% CI -1.10 to 4.41, p=0.24).
Systematic review Wijnia 2024 ✓ PubMed
Systematic literature review of 27 studies (including 1 RCT) found IV thiamine alleviates neurological symptoms, cognitive dysfunction, and MRI lesions in Wernicke's encephalopathy, but evidence remains too limited to define optimal dose, route, or duration.
Meta-analysis Puertas-Miranda 2025 ✓ PubMed
Meta-analysis of 12 studies (5,510 patients) found Wernicke encephalopathy was 65.4% male (weighted mean age 60.7 yr); alcohol-related and non-alcohol-related cases differed in presentation, underscoring under-recognition of WE outside alcohol use.
Systematic review Pediatric WE Review 2025 ✓ PubMed
Systematic review of 88 pediatric Wernicke encephalopathy cases over 30 years found higher parenteral thiamine doses correlated with faster recovery, with full remission in 61% of cases.
Meta-analysis Thiamine Septic Shock Meta-analysis 2023 ✓ Full text
Meta-analysis of RCTs with trial sequential analysis found thiamine alone did not significantly reduce mortality in septic shock (RR 0.87, 95% CI 0.65-1.16, I2=21%, p=0.34).
systematic review Gomes et al. 2021 review ✓ Full text
Thiamine deficiency in high-income countries occurs well beyond alcoholism — driven by malnutrition, bariatric surgery, chronic diuretics, vomiting, and restrictive diets (81 confirmed cases across 17 reports).
randomized controlled trial PBC chronic fatigue crossover RCT 2024 ✓ Full text
High-dose oral thiamine did not significantly reduce chronic fatigue versus placebo in patients with primary biliary cholangitis.
randomized controlled trial Stracke et al. 2008 (BENDIP RCT) ✓ PubMed
In 165 diabetic polyneuropathy patients, benfotiamine improved Neuropathy Symptom Score vs placebo (per-protocol p=0.033; ITT p=0.055), dose-dependently.
reference review StatPearls: Vitamin B1 (Thiamine) ✓ Full text
TPP is the essential coenzyme for pyruvate/alpha-ketoglutarate dehydrogenase and transketolase; deficiency causes beriberi and Wernicke-Korsakoff syndrome.
authoritative body NIH ODS Thiamin (2023) ✓ Source
Adult RDA 1.2 mg (men)/1.1 mg (women); no UL set due to absence of reported toxicity from high intakes.

Common questions about Vitamin B1 (Thiamine)

What is Vitamin B1 (Thiamine) used for?

Vitamin B1 (Thiamine) is most often taken for Corrects and prevents deficiency syndromes — beriberi (cardiac and neuropathic) and, with prompt IV dosing, Wernicke-Korsakoff syndrome in alcohol-use disorder, Repletes high-risk groups: heavy alcohol use, chronic loop-diuretic (furosemide) therapy, bariatric surgery, hyperemesis, refeeding syndrome, and critical illness, Essential cofactor (as thiamine pyrophosphate) for pyruvate and alpha-ketoglutarate dehydrogenase and transketolase, enabling carbohydrate energy metabolism, Benfotiamine (lipid-soluble form) gives modest, dose-dependent symptom relief in diabetic polyneuropathy (BENDIP) — though not a benefit of standard thiamine in non-deficient people. The energy-metabolism spark plug — vital when deficient, inert when you're not

Does Vitamin B1 (Thiamine) work — what does the evidence say?

Strong evidence. Multiple high-quality RCTs / meta-analyses with consistent effects. Thiamine (vitamin B1) is an essential water-soluble vitamin whose active form, thiamine pyrophosphate, is a coenzyme for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase — reactions central to carbohydrate metabolism and ATP production. Deficiency causes beriberi (wet/cardiac and dry/neuropathic forms) and, classically in alcohol-use disorder, Wernicke-Korsakoff syndrome; high-risk groups include heavy drinkers, those on chronic loop diuretics, bariatric-surgery and critically ill patients. In non-deficient people, supplementation trials are largely null: a 2024 meta-analysis of 7 RCTs found no improvement in LVEF in chronic heart failure, and high-dose thiamine did not relieve chronic fatigue versus placebo in a crossover RCT. The lipid-soluble derivative benfotiamine shows modest, dose-dependent symptom benefit in diabetic polyneuropathy but evidence remains limited.

What is the typical dose of Vitamin B1 (Thiamine)?

Adult RDA: 1.2 mg/day (men), 1.1 mg/day (women); 1.4 mg/day in pregnancy and lactation. Typical supplements supply 1.5-100 mg. Therapeutic doses are far higher — e.g., 100 mg+ IV thiamine for Wernicke encephalopathy, or benfotiamine 300-600 mg/day in neuropathy trials. No Tolerable Upper Intake Level (UL) has been established; excess is readily excreted in urine.

Is Vitamin B1 (Thiamine) safe? Any cautions or side effects?

Thiamine has very low toxicity and no established UL — excess oral intake is excreted renally, and adverse effects from food or supplements have not been documented. Rare anaphylactoid reactions have been reported with rapid high-dose IV administration. In suspected Wernicke encephalopathy, thiamine must be given before or with glucose, since a glucose load in a thiamine-depleted patient can precipitate or worsen encephalopathy. Chronic loop diuretics (furosemide) and heavy alcohol use increase urinary loss/impair absorption and raise deficiency risk; no major drug interactions limit supplementation itself.

How many studies support Vitamin B1 (Thiamine)?

NutriDex cites 10 sources for Vitamin B1 (Thiamine), graded "Strong".

Cite this page
APA

Peh, D. (2026). Vitamin B1 (Thiamine): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 26 Jun 2026, from https://nutridex.info/s/vitamin-b1

BibTeX
@misc{nutridex_vitamin_b1,
  author       = {Peh, Daryl},
  title        = {Vitamin B1 (Thiamine): Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/vitamin-b1},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-06-26}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances